Table 3.

Correlation of the expression of CXCL8 with clinicopathologic features

Clinicopathologic features	n (%)	Relative expression of CXCL8		P
		Low	High
Age (year)
< 50	32 (44.4%)	19	13	0.997
≥50	40 (55.6%)	22	18
Sex
Male	39 (54.2%)	20	19	0.946
Female	33 (45.8%)	18	15
Serum AFP level (ng/mL)
< 20	14 (19.4%)	5	9	0.008**
≥20	58 (80.6%)	46	12
Tumor size (cm)
< 5	26 (36.1%)	5	21	0.009**
≥5	46 (63.9%)	39	7
TNM tumor stage
I+II	51 (70.8%)	15	36	0.023*
III+IV	21 (29.2%)	18	3

Compared with low CXCL8 expression group;

^*P < 0.05;

^**P < 0.01.